Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage: Hospital-based, case-control study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 6, 2010, Pages 679-684

  Gregoire, S M ^a   Jager H R ^a   Yousry, T A ^a   Kallis, C ^b   Brown, M M ^a   Werring, David J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN MICROBLEED; CONTROLLED STUDY; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR;

EID: 77953702963     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.198994     Document Type: Article

References (32)

1. Saloheimo P, Ahonen M, Juvela S, et al. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke 2006;37:129-33.
2. Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy. Recent data and ideas. Stroke 2005;36:1588-93.
3. He J, Whelton PK, Vu B, et al. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 1998;280:1930-5. (Pubitemid 28559811)
4. Gorelick PB, Weisman SM. Risk of hemorrhagic stroke with aspirin use: an update. Stroke 2005;36:1801-7.
5. Baigent C, Blackwell L, Collins R, et al. Antithrombotic Trialists' (ATT) Collaboration; Aspirin in the primary prevention and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849-60.
6. Kronmal RA, Hart RG, Manolio TA, et al; CHS Collaborative Research Group. Aspirin use and incident stroke in the cardiovascular health study. CHS Collaborative Research Group. Stroke 1998;29:887-94.
7. Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 2007;68:116-21.
8. Algra A, Gorter JW, Kappelle LJ, et al. Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 1997;42:857-65.
9. Smith EE, Rosand J, Knudsen KA, et al. Leukoaraiosis is associated with Warfarin-related hemorrhage following ischemic stroke. Neurology 2002;59:193-7. (Pubitemid 34779176)
10. Greenberg SM, Eng JA, Ning M, et al. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 2004;35:1415-20.
11. Jeon SB, Kang DW, Cho AH, et al. Initial microbleeds at MR imaging can predict recurrent intracerebral hemorrhage. J Neurol 2007;254:508-12.
12. Werring DJ, Coward LJ, Losseff NA, et al. Cerebral microbleeds are common in ischemic stroke but rare in TIA. Neurology 2005;65:1914-18.
13. Vernooij MW, van der Lugt A, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study. Neurology 2008;70:1208-14.
14. Vernooij MW, Haag MD, van der Lugt A, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds. The Rotterdam Scan Study. Arch Neurol 2009;66:714-20.
15. Soo YO, Yang SR, Lam WW, et al. Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol 2008;255:1679-86.
16. Gregoire SM, Chaudhary UJ, Jäger HR, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology 2009;73:1759-66.
17. Wahlund LO, Barkhof F, Fazekas F, et al. European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318-22.
18. Bryan RN, Cai J, Burke G, et al. Prevalence and anatomic characteristics of infarct-like lesions on MR images of middle-aged adults: the Atherosclerosis Risk in Communities Study. Am J Neuroradiol 1999;20:1273-80. (Pubitemid 29400539)
19. Kwon HM, Kim BJ, Lee SH, et al. Metabolic syndrome as independent risk factor for silent brain infarction in healthy people. Stroke 2006;37:466-70.
20. Naka H, Nomura E, Takahashi T, et al. Combinations of the presence or absence of cerebral microbleeds and advanced white matter hyperintensity as predictors of subsequent stroke subtypes. Am J Neuroradiol 2006;27:830-5. (Pubitemid 44897731)
21. Roob G, Lechner A, Schmidt R, et al. Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke 2000;31:2665-9.
22. Tsushima Y, Aoki J, Endo K. Brain Microhemorrhages detected on T2*-Weighted Gradient-Echo MR images. Am J Neuroradiol 2003;24:88-96. (Pubitemid 36110106)
23. Greenberg SM. Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology 1998;51:690-4.
24. Rosand J, Hylek EM, O'Donnell HC, et al. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 2000;55:947-51.
25. Wong KS, Mok V, Lam WW, et al. Aspirin-associated intracerebral hemorrhage: clinical and radiologic features. Neurology 2000;54:2298-301. (Pubitemid 30416281)
26. McCarron MO, Nicoll JA. Cerebral amyloid angiopathy and thrombolysis-related Intracerebral haemorrhage. Lancet Neurol 2004;3:484-92.
27. Wong KS, Chan YL, Liu JY, et al. Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages. Neurology 2003;60:511-13.
28. Huang Y, Cheng Y, Wu J, et al. Cilostazol versus Aspirin for Secondary Ischaemic Stroke Prevention cooperation investigators. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomized, double-blind, pilot study. Lancet Neurol 2008;7:494-9.
29. Fan YH, Zhang L, Lam WW, et al. Cerebral Microbleeds as a risk factor for subsequent intracerebral haemorrhages among patients with acute ischaemic stroke. Stroke 2003;34:2459-62.
30. Boulanger JM, Coutts SB, Eliasziw M, et al; Vision Study Group. Cerebral microhemorrhages predict new disabling or fatal strokes in patients with acute ischaemic stroke or transient ischaemic attack. Stroke 2006;37:911-14.
31. Diener HC, Bogousslavsky J, Brass LM, et al; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 2004;364:331-7.
32. Jeong SW, Jung KH, Chu K, et al. Clinical and radiologic differences between primary intracerebral hemorrhage with and without microbleeds on gradient-echo magnetic resonance images. Arch Neurol 2004;61:905-9.